Showing 11,901 - 11,920 results of 45,491 for search '(( 5 ((ng decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 1.08s Refine Results
  1. 11901

    Data Sheet 3_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  2. 11902

    Data Sheet 8_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  3. 11903

    Data Sheet 4_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  4. 11904

    Data Sheet 5_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  5. 11905

    Data Sheet 2_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  6. 11906
  7. 11907
  8. 11908

    MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme by Alexandra Sufit (3270084)

    Published 2016
    “…GBM cell lines (A172, SF188, U251) were treated in vitro with increasing doses of UNC2025 (50-400nM). …”
  9. 11909
  10. 11910
  11. 11911
  12. 11912

    Change in fish functional diversity and assembly rules in the course of tidal marsh restoration by Alain Lechêne (6103274)

    Published 2018
    “…Environmental filtering tended to decrease in restored and natural intertidal habitats. …”
  13. 11913
  14. 11914

    Effects of busulfan treatment on CX43 and N-Cadherin. by Lingjun Zhao (21763122)

    Published 2025
    “…<p>The gap junction protein CX43 (A) and the ectoplasmic specialization-related protein N-Cadherin (B) were detected by immunofluorescence assay. …”
  15. 11915

    Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate by Jairo E. Perez-Franco (3166050)

    Published 2016
    “…<i>braziliensis</i> (95.4%) and 35% of the parasites isolated showed a significant decrease in <i>in vitro</i> Glucanatime susceptibility associated with previous administration of the medicament. …”
  16. 11916
  17. 11917

    Sequence parameters. by Tobit Führes (12647099)

    Published 2023
    “…Seven healthy volunteers underwent diffusion-weighted magnetic resonance imaging (DWI) with five diffusion encoding schemes (monopolar, velocity-compensated (<i>M</i><sub>1</sub> = 0), acceleration-compensated (<i>M</i><sub>1</sub> = <i>M</i><sub>2</sub> = 0), 84%-<i>M</i><sub>1</sub>–<i>M</i><sub>2</sub>-compensated, 67%-<i>M</i><sub>1</sub>–<i>M</i><sub>2</sub>-compensated) at b-values of 50 and 800 s/mm<sup>2</sup> at a constant echo time of 70 ms. …”
  18. 11918

    ADC maps of one volunteer. by Tobit Führes (12647099)

    Published 2023
    “…Seven healthy volunteers underwent diffusion-weighted magnetic resonance imaging (DWI) with five diffusion encoding schemes (monopolar, velocity-compensated (<i>M</i><sub>1</sub> = 0), acceleration-compensated (<i>M</i><sub>1</sub> = <i>M</i><sub>2</sub> = 0), 84%-<i>M</i><sub>1</sub>–<i>M</i><sub>2</sub>-compensated, 67%-<i>M</i><sub>1</sub>–<i>M</i><sub>2</sub>-compensated) at b-values of 50 and 800 s/mm<sup>2</sup> at a constant echo time of 70 ms. …”
  19. 11919
  20. 11920